Nextel Medical Corp. (MAJI) shareholders
Close on Oct 19, 2026Market cap $849.47KP/E –Yield –
Ownership
Who owns Nextel Medical's shares
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Donald Ross Director | Jun 6, 2013 | Sale | −16,500,000 | $0.01 | $165.00K | 1,394,263 |
| David J. Cutler Chief Financial Officer, Director | Apr 9, 2013 | Award | +150,000 | – | – | 650,000 |
| Stephen E. Flechner President, CEO, Director | Apr 9, 2013 | Award | +300,000 | – | – | 1,850,000 |
| Stephen E. Flechner President, CEO, Director | Jan 21, 2013 | Award | +250,000 | – | – | 1,550,000 |
| David J. Cutler Chief Financial Officer, Director | Jan 21, 2013 | Award | +200,000 | – | – | 500,000 |
| Stephen E. Flechner President, CEO, Director | Nov 7, 2012 | Award | +300,000 | – | – | 1,300,000 |
| David J. Cutler Chief Financial Officer, Director | Nov 7, 2012 | Award | +300,000 | – | – | 300,000 |
| Ralph Edward Shearing Director | Oct 9, 2012 | Award | +53,846 | $0.13 | $7.00K | 553,846 |
| Ralph Edward Shearing Director | Oct 9, 2012 | Award | +25,641 | $0.14 | $3.59K | 579,487 |
| Donald Ross Director | Sep 29, 2012 | Award | +1,109,041 | $0.10 | $110.90K | 17,609,041 |
| Donald Ross Director | Sep 29, 2012 | Award | +285,222 | $0.10 | $28.52K | 17,894,263 |
| Shelley Guidarelli 10% owner | Aug 30, 2012 | Sale | −1,100,000 | – | – | 4,900,000 |
| Dean Scott Huge Chief Financial Officer, Director | Aug 17, 2012 | Award | +150,000 | – | – | 950,000 |
| Stephen E. Flechner President, CEO, Director | Aug 17, 2012 | Award | +400,000 | – | – | 1,000,000 |
| Stephen E. Flechner President, CEO, Director | Jun 5, 2012 | Award | +200,000 | – | – | 600,000 |
| Dean Scott Huge Chief Financial Officer, Director | Jun 5, 2012 | Award | +100,000 | – | – | 800,000 |
| Ralph Edward Shearing Director | Jun 5, 2012 | Award | +100,000 | – | – | 500,000 |
| Dean Scott Huge Chief Financial Officer, Director | May 25, 2012 | Award | +100,000 | – | – | 700,000 |
| Stephen E. Flechner President, CEO, Director | May 25, 2012 | Award | +200,000 | – | – | 400,000 |
| Ralph Edward Shearing Director | May 25, 2012 | Award | +100,000 | – | – | 400,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nextel Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 40,428 shares on Oct 5, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Donald Steinberg 10% Stockholder | May 8, 2025 | 350,000 | $70.00K | May 7, 2025 | Stock purchase |
| Blue Ridge Enterprises LLC/Donald Steinberg CEO | Sep 8, 2023 | 380,000 | $76.00K | Sep 7, 2023 | Purchase Contract |
See a number that looks wrong?